Furthermore, studies have also shown that vWF controls the levels of ANG2 secreted by activated ECs via VEGFR2, resulting in blood vessel disruption and angiogenesis [10,15], consistent with the phenotype detected in lipedema tissue. Here, ANGPT2 is linked to Lipedema.